Net Cash Provided by (Used in) Financing Activities of Maze Therapeutics, Inc. from 31 Mar 2024 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Maze Therapeutics, Inc. quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Mar 2024 to 31 Mar 2025.
  • Maze Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $127,378,000, a 418% increase year-over-year.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

Maze Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $127,378,000 +$102,797,000 +418% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q1 2024 $24,581,000 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.